KERBI ELSENBROEK: Open Payments
NPI 1801119771 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,530 in 142 payments from 18 companies in 2025. Trend: 2023 $2,147 · 2024 $1,880 · 2025 $2,530
Food & beverage: $2,524Education: $7
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $390 |
| Incyte Corporation | 13 | $304 |
| Arcutis Biotherapeutics, Inc. | 26 | $257 |
| Regeneron Healthcare Solutions, Inc. | 11 | $234 |
| Organon LLC | 12 | $196 |
| ABBVIE INC. | 12 | $175 |
| Galderma Laboratories, L.P. | 16 | $168 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $160 |
| Novartis Pharmaceuticals Corporation | 5 | $135 |
| GENZYME CORPORATION | 6 | $122 |
Products named: Bimzelx, DUPIXENT, OPZELURA, Zoryve, NEMLUVIO, VTAMA, Winlevi, CIBINQO.
Industry payments across TX — which companies pay providers there.
